October 25, 2019 (MLN): GlaxoSmithKline Consumer Healthcare (GSKCH) has announced its financial results for the nine months ended on September 30, 2019. The company has witnessed a growth of 5% in its net profit, clocked in at Rs 888 million as compared to the same period of last year.
During the period, the company’s net revenues were up by 8.81%, but more than a proportionate increase in the cost of sales made the gross profits increased by 7.74%.
The marketing and distribution expenses soared by 10.77%, whereas administrative expenses dropped by 13.86%.
More notably, the company’s other income declined by around 66%, from Rs.123 million to Rs.41 million, YoY.
Moreover, GSKCH’s basic and diluted earnings per share have been reported at Rs.7.59 per share while those recorded last year were Rs.7.23 per share.
Financial Results for the nine months ended September 30th 2019 (Rupees)
| |||
|---|---|---|---|
Sep-19 | Sep-18 | % Change | |
Net sales | 11,812,260,072 | 10,856,290,137 | 8.81% |
Cost of sales | (8,026,525,766) | (7,342,466,967) | 9.32% |
Gross profit | 3,785,734,306 | 3,513,823,170 | 7.74% |
Selling, marketing and distribution expenses | (2,138,610,379) | (1,930,640,388) | 10.77% |
Administrative expenses | (185,675,547) | (215,548,177) | -13.86% |
Other operating expenses | (101,571,312) | (99,365,233) | 2.22% |
Other income | 41,895,328 | 123,499,398 | -66.08% |
Operating profit/(loss) | 1,401,772,396 | 1,391,768,770 | 0.72% |
Financial cost | (163,252,105) | (207,572,857) | -21.35% |
Profit/(loss) before taxation | 1,238,520,291 | 1,184,195,913 | 4.59% |
Taxation | (350,178,072) | (338,243,495) | 3.53% |
Profit/(loss) after taxation | 888,342,219 | 845,952,418 | 5.01% |
Earnings per share – basic and diluted (Rupees) | 7.59 | 7.23 | 4.98% |
Copyright Mettis Link News
30770
